Skip to main content
Back to HSG

HSG's Pharmaceutical Portfolio

Browse 27 Pharmaceutical companies funded by HSG. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
27
Total Funding in Pharmaceutical
$2.4B

Pharmaceutical Portfolio Companies (27)

Export
BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
$250.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

South San Francisco, United States
April 2025
$8.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company

Singapore, Singapore
March 2026
$40.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Cambridge, United States
March 2025
$123.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Princeton, United States
February 2026
$85.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

San Diego, United States
May 2023
$35.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

South San Francisco, United States
December 2025
$747.5M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

New Haven, United States
January 2022
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases

San Diego, United States
January 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceutical

HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.

Suzhou, China
December 2025
$17.1M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Full-Life Technologies is a medical company providing development, production, and commercialization of medicines for cancer therapy.

Shanghai, China
September 2025
$50.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Hangzhou, China
August 2025
$55.7M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Suzhou, China
July 2025
$59.7M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Dizal Pharma is a biotechnology company that conducts research for the treatment of cancer and immunological diseases.

Shanghai, China
April 2025
$246.2M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.

Guangzhou, China
June 2023
$14.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Beijing, China
May 2023
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedicalPharmaceutical

Grit Science is a gene therapeutics firm.

Beijing, China
March 2022
$15.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CarePharmaceuticalProduct Research

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

Hangzhou, China
July 2021
$15.5M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareInnovation ManagementPharmaceutical

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

Beijing, China
March 2021
$155.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaDeliveryHealth CarePharmaceutical

LP Pharmaceuticals is a pharmaceutical company.

Xiamen, China
August 2020
$72.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyClinical TrialsHealth CarePharmaceutical

Yaoyanshe is a CRO technology platform that focuses on providing innovative clinical research services for the medical industry.

Shanghai, China
August 2020
$86.2M
Series D

Founder Contacts

30,000+ verified contacts

Health CareInformation TechnologyInternetMedicalPharmaceutical

Yaobangmang is a pharmaceutical platform that integrates drug procurement, warehousing, sales, and logistics distribution.

Wuhan, China
October 2018
$10.1M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceutical

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

Hsinchu, Taiwan
October 2018
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio